findmyKOL

Selma Mohammed, MD, PhD

Basic profile

Creighton University

ORCIDNPI
RegionOmaha, NE · MidwestSpecialtyAdvanced Heart Failure and Transplant CardiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Selma Mohammed is a Cardiology physician affiliated with Creighton University. OpenAlex indexes 141 publications with 3,899 citations (h-index 25).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
141publications

Distinct works indexed by OpenAlex, matched via ORCID.

3,899citations

Total citations across indexed works.

25h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

7500 Mercy Rd
Omaha, NE 681242319

Telephone

402-398-5880

Provider last certified this registry record 5 Mar 2021.

View the NPPES registry record

Industry payments

2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    78.8%
    Aldosterone antagonist (MRA)17.5%
    Spironolactone90%Eplerenone10%
    Part D<11 patients
    Beta blocker17%
    Metoprolol Succinate64%Carvedilol27%Metoprolol Tartrate9%
    Part D<11 patients

    + 11 more classes in this area

  • Metabolism & gastrointestinal

    13.5%
    SGLT2 inhibitor10.3%
    Farxiga74%Jardiance26%
    Part D52 patients
    Potassium supplement3.2%
    Potassium Chloride100%
    Part D46 patients
  • Blood & clotting

    7.3%
    Factor Xa inhibitor5.8%
    Eliquis88%Xarelto12%
    Part D<11 patients
    Vitamin K antagonist0.8%
    Warfarin Sodium100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)37% facility · 63% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”